Unlocking the genetic roots of fibromyalgia's pain puzzle

NCT ID NCT04624581

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study investigates whether genetic differences and altered pain processing contribute to fibromyalgia, a condition marked by widespread pain and increased sensitivity to painful stimuli. Researchers will compare 260 adults with fibromyalgia to a matched control group, measuring pain thresholds via a nerve reflex test and analyzing genetic variations. The goal is to better understand the biological mechanisms behind fibromyalgia, which could inform future diagnostic or treatment strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Electrophysiological measurement of reflex nociceptive flexion threshold (RIII reflex) using Nicolet Vicking device
What this could lead to
If successful, this research could uncover genetic markers that help explain why fibromyalgia develops, potentially leading to more personalized diagnosis or treatment approaches.
What could go wrong
This is an observational study, so it won't test a treatment. The findings may not directly translate into new therapies, and genetic associations may be complex and require further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain fibromyalgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.